41 cases of prostaglandin E1 and dobutamine treatment of intractable heart failure（41例前列腺素E1和多巴酚丁胺治疗棘手的心脏衰竭）.docVIP

下载本文档

4
0
约6.2千字
约 6页
2017-09-05 发布于浙江
举报
版权申诉

41 cases of prostaglandin E1 and dobutamine treatment of intractable heart failure（41例前列腺素E1和多巴酚丁胺治疗棘手的心脏衰竭）.doc

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

41 cases of prostaglandin E1 and dobutamine treatment of intractable heart failure（41例前列腺素E1和多巴酚丁胺治疗棘手的心脏衰竭）

41 cases of prostaglandin E1 and dobutamine treatment of intractable heart failure Papers to write network: Author: Wang Shuxiang high positive the mountain Zhang Yushun behalf of political science Chen Yuqi [Keywords] intractable heart failure Keywords: refractory heart failure; prostaglandin E1; dobutamine 0 Introduction Refractory heart failure (RHF is the comprehensive treatment by digitalis, diuretics and vascular vasodilators, difficult to control clinical signs and symptoms of heart failure treatment more difficult and higher mortality. Since 2000-08/2001 the -09 application of prostaglandin E1 (PGE1 with dobutamine infusion treatment RHF41 of patients achieved a satisfactory effect. 1 objects and methods Ⅳ grade (NYHA functional class the the PHF 81 patients, cardiac function were randomly divided into a treatment group, 41 (28 male, 13 female, average age of 67 (45 to 75 years) including 13 cases of chronic pulmonary heart disease dilated cardiomyopathy in 9 cases, 8 cases of rheumatic heart disease, six cases of coronary heart disease, hypertensive heart disease, degenerative joint valvular disease patients in the control group 40 (26 male, 14 female, mean age 66.5 ( 43 to 78 years old. including 12 cases of chronic pulmonary heart disease, eight cases of dilated heart disease, rheumatic heart disease, nine cases, seven cases of coronary heart disease, hypertensive heart disease between the two groups of patients by age, sex and was no significant difference in the disease, the application of the control group oxygen, as appropriate, to digitalis, diuretics, Capoten, symptomatic and supportive treatment group on the basis of the comprehensive treatment, the PGE 1 200μg, dobutamine 100mg each added 50g L-1 glucose 250mL intravenous infusion, 10 to 15 drops min-1 d-1, monitoring of blood pressure, heart rate, treatment 7d observation project and efficacy criteria : ① The efficacy judgment: after treatment, heart function improve more th